Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39082668

Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2024 Oct 31
First author
Al-Sawaf O

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2024 Oct 31;144(18):1849-1850. doi: 10.1182/blood.2024025896.
    note
    Source null
    related pmid
    39480414
    relationship
    Comment in

Authors and identifiers

  1. name
    Al-Sawaf O
    type
    Author
  2. name
    Robrecht S
    type
    Author
  3. name
    Zhang C
    type
    Author
  4. name
    Olivieri S
    type
    Author
  5. name
    Chang YM
    type
    Author
  6. name
    Fink AM
    type
    Author
  7. name
    Tausch E
    type
    Author
  8. name
    Schneider C
    type
    Author
  9. name
    Ritgen M
    type
    Author
  10. name
    Kreuzer KA
    type
    Author
  11. name
    Sivchev L
    type
    Author
  12. name
    Niemann CU
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Al-Sawaf O
    type
    Author
  2. name
    Robrecht S
    type
    Author
  3. name
    Zhang C
    type
    Author
  4. name
    Olivieri S
    type
    Author
  5. name
    Chang YM
    type
    Author
  6. name
    Fink AM
    type
    Author
  7. name
    Tausch E
    type
    Author
  8. name
    Schneider C
    type
    Author
  9. name
    Ritgen M
    type
    Author
  10. name
    Kreuzer KA
    type
    Author
  11. name
    Sivchev L
    type
    Author
  12. name
    Niemann CU
    type
    Author
bibliography ids
  1. nci-bib-e26c5fa27a62daa70dbbfaa3
book metadata
content sha256
ac1f2abbd123cdc98453f5627e1d3c70cb8fc6e9e5a63b7c97766e0858d6cd9d
document type
citation
dois
  1. 10.1182/blood.2024024631
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:39082668
immutable id
pubmed:39082668@ac1f2abbd123cdc98453f5627e1d3c70cb8fc6e9e5a63b7c97766e0858d6cd9d
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
18
name
Blood
nlm unique id
7603509
pages
1924-1935
volume
144
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2024 Oct 31;144(18):1849-1850. doi: 10.1182/blood.2024025896.
    note
    Source null
    related pmid
    39480414
    relationship
    Comment in
outcomes validated
false
pmid
39082668
provenance
batch id
3e43afde6f26fc8df6da
provider
NCBI PubMed ESummary
record sha256
6288b2bade8a580a338c9b6adad27eb706a3d7a7ff570b347e335327dd3ff0fe
response sha256
fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
retrieved at
2026-09-09T23:48:21.145285+00:00
publication date
display
2024 Oct 31
precision
day
year
2024
publication types
  1. Journal Article
  2. Clinical Trial, Phase III
  3. Randomized Controlled Trial
  4. Multicenter Study
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/39082668/
title
Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study.

Preserved source evidence · Not medical advice